EBITDA 1,548 1,814 (14.7) 1,561 (0.8) EBITDA

Similar documents
Dalmia Bharat Enterprises

EBITDA 2,503 2,904 (13.8) 2,722 (8.0) EBITDA

EBITDA 1,585 1,917 (17.3) 1,673 (5.2) EBITDA

EBITDA 6,223 6,511 (4.4) 5, EBITDA

Dalmia Bharat Enterprises

EBITDA 5,076 3, , EBITDA

Institutional Equities

Dalmia Bharat Enterprises

Indian Oil Corporation

Gillette India. Institutional Equities. 2QFY19 Result Update BUY. Marketing Investments Mask Improved Top-line Performance

Jamna Auto Industries

Power Mech Projects. Institutional Equities. 2QFY19 Result Update BUY. Strong Order Book Drives Robust Execution

Mangalam Cement. Institutional Equities. 3QFY18 Result Update. Higher Operating costs Hurt Performance BUY

Colgate-Palmolive (India)

The Ramco Cements. Institutional Equities. Event Update BUY

Gillette India. Institutional Equities. 1QFY18 Result Update

Sanofi India. Institutional Equities. 3QCY18 Result Update. Robust Performance BUY

ITC. Institutional Equities. 4QFY18 Result Update. Tracking Expectations ACCUMULATE. Sector: FMCG CMP: Rs286 Target Price: Rs290 Upside: 1%

ACC. Institutional Equities. Event Update. Capacity Expansion To Consolidate Presence In Central India ACCUMULATE

Punjab National Bank

NESCO. Institutional Equities. Event Update. Revenues From Bombay Exhibition Centre May Take A Hit BUY

Indian Oil Corporation

South Indian Bank. Institutional Equities. 4QFY18 Result Update. Asset Quality Pain To Ease Hereafter BUY. 15 May 2018

Thermax. Institutional Equities. 3QFY18 Result Update. Healthy Execution, But Margins Disappoint SELL

Institutional Equities

Bata India. Institutional Equities. 1QFY19 Result Update BUY

Mold-Tek Packaging. Institutional Equities. Conference Update. Promising Growth Outlook BUY

26 October 2018 Reuters: MRTI.BO; Bloomberg: MSIL IN

Institutional Equities

Swaraj Engines. Institutional Equities. 2QFY18 Result Update ACCUMULATE

Institutional Equities

Nestle India. Institutional Equities. 1QCY18 Result Update. Resurgence Continues BUY. Sector: FMCG CMP: Rs8,981 Target Price: Rs10,700 Upside: 19%

Punjab National Bank

Power Mech Projects. Institutional Equities. 2QFY18 Result Update BUY. Strong Business Scalability Likely; Retain Buy

Voltas. Institutional Equities. 1QFY19 Result Update. EMPS Shines, UCP Proves Its Mettle Again ACCUMULATE

Eicher Motors. Institutional Equities. Management Meet Update BUY. Reuters: EICH.NS; Bloomberg: EIM IN

Institutional Equities

TVS Motor Company. Institutional Equities. 3QFY19 Result Update SELL

Karnataka Bank. Institutional Equities. 4QFY18 Result Update. Plucky Bank And Low Hanging Fruit BUY. 17 May Reuters: KBNK.NS; Bloomberg: KBL IN

Institutional Equities

Timken India. Institutional Equities. 4QFY16 Result Update BUY. Margin Expansion Leads To Huge Growth In Profit; Retain Buy

Institutional Equities

EBITDA 5,019 4,211 5, EBITDA

Institutional Equities

3,746 2,551 3, NIM

PNB Housing Finance. Institutional Equities. 4QFY18 Result Update BUY. Continued Display of Embedded Scalability. 4 May 2018

Manappuram Finance. Institutional Equities. 3QFY18 Result Update. The Glitter Is Back In Gold Loans BUY. 9 February 2018

Consolidated Sales (Cr) Growth EBITDA (Cr) Margin PAT Margin EPS (Rs) P/E RoE

Crompton Greaves. Institutional Equities. 4QFY15 Result Update ACCUMULATE. Overseas Losses Continue; More Business Exits Likely

2,09,057 1,85,859 2,17, (4.1) NIM

Crisil. Institutional Equities. 3QCY17 Result Update ACCUMULATE. Weak SME Rating Revenues & Currency Movement Play Spoilsport

Dabur India. Institutional Equities. 1QFY19 Result Update

Muthoot Finance. Institutional Equities. 1QFY18 Result Update. Gold Loan Business Continues To Glitter BUY. 10 August 2017

Dabur India. Institutional Equities. 4QFY18 Result Update. Growth Volatility Is Still Fairly High ACCUMULATE

Institutional Equities

Hindustan Unilever. Institutional Equities. 4QFY18 Result Update

9,500 7,914 8, NIM

Muthoot Finance. Institutional Equities. 3QFY18 Result Update. Funding Cost Decline Combines With Operating Leverage BUY.

Bharat Financial Inclusion

CARE Ratings. Institutional Equities. 2QFY18 Result Update BUY

Muthoot Finance. Institutional Equities. 2QFY18 Result Update BUY

18,948 15,784 18, NIM

Hindustan Unilever. Institutional Equities. 1QFY19 Result Update

IFB Industries. Institutional Equities. 3QFY18 Result Update. Healthy Revenues, Strong Gross Margin; Retain Buy BUY.

Bajaj Electricals. Institutional Equities. 3QFY15 Result Update

E&P To Stay Strong; Consumer Segment To Revive

Sequent Scientific. Institutional Equities. 1QFY19 Result Update BUY

Initiating Coverage. Uflex Ltd.

93,707 77,814 90, NIM

Institutional Equities

Punjab National Bank

Punjab National Bank

Institutional Equities

La Opala RG. Institutional Equities. 4QFY17 Result Update UNDER REVIEW. Revenues Soar, But Margins Take A Hit. Sector: Tableware CMP: Rs536

Bata India. Institutional Equities. Management Meet Update. On Right Track ACCUMULATE. Sector: Retail CMP: Rs692 Target Price: 696 Upside: 1%

PNB Housing Finance. Institutional Equities. 2QFY19 Result Update BUY. Relatively Soft Quarter Not Structural In Nature.

Punjab National Bank

Institutional Equities

Atul Auto. Institutional Equities. Management Meet Update ACCUMULATE. Sector: Automobile CMP: Rs445 Target Price: Rs489 Upside: 10% 23 August 2017

Institutional Equities

Muthoot Finance. Institutional Equities. 1QFY19 Result Update

Muthoot Finance. Institutional Equities. 2QFY19 Result Update. Weak quarter not structural in any way BUY. 10 December 2018

South Indian Bank. Institutional Equities. 1QFY19 Result Update. Performance Troughs, Pessimism Peaks BUY. 23 July 2018

Manappuram Finance. Institutional Equities. 3QFY17 Result Update BUY

Cement Sector 6 June 2018

Cadila Healthcare. Institutional Equities. 3QFY15 Result Update UNDER REVIEW. Stable Performance. Sector: Pharmaceuticals CMP: Rs1,514

9,251 7,812 8, NIM

Institutional Equities

V-Guard Industries. Institutional Equities. Conference-call Update BUY. Sector: White Goods CMP: Rs914 Target Price: Rs1,109 Upside: 21%

Operating expenses tracked lower than core total income growth as ABL displayed continued

State Bank of India. Institutional Equities. 1QFY18 Result Update

State Bank of India. Institutional Equities. 3QFY19 Result Update BUY

Robust results, TLT margins improved profitability.

9,807 8,007 9, NIM

La Opala RG. Institutional Equities. 1QFY18 Result Update

Cement Sector 27 February 2018

Swiss Glascoat Equipments

KEC International. Institutional Equities. Management Meet Update BUY. On Course Towards Recovery In Operating Margin

Institutional Equities

Manappuram Finance. Institutional Equities. 2QFY19 Result Update BUY

Transcription:

Result Update The India Cements 12 November 218 Reuters: ICMN.BO; Bloomberg: ICEM IN Lackluster Performance The India Cements (ICEM) reported a listless operating performance in because of the sustained fall in realisation. Cement volume continued to pick up with ~14.% YoY growth at 3.8mnmt (above our estimate of 3.3mnmt). However, realisation continued to decline ~2% YoY to Rs4,58/tn. Effectively, revenues grew only ~9% YoY to ~Rs13.9bn (marginally above our estimate of ~Rs13.7bn). Operating costs were flat YoY (but up 2.2% QoQ) at Rs4,4/tn because of savings in logistics costs and other expenditure. Continued weakness in realisation owing to demand-supply imbalance in key ICEM markets led to EBITDA margin compression of 31bps YoY to 11.2% YoY. Effectively, EBITDA/tn fell sharply to Rs53/tn, down ~24% YoY (in line with our estimate of Rs51/tn). Interest expenses (adjusted for foreign exchange losses of Rs118.1mn) declined 6% YoY to Rs836mn. Adjusted PAT in stood at Rs132mn, a sharp fall 44%YoY and ~37% QoQ. Considering the weak performance (higher slippage than estimated), we have revised downward our estimates. Although was the toughest quarter with limited pass-through and cost increase in some pockets, we feel ICEM s performance is unlikely to improve (better than industry) and stage a quick reversal. Cost pressure is likely to continue and price reversal in key ICEM markets will be slow. Effectively, balance sheet weakness will lead to higher debt and increased interest costs. Factoring in the same, we have revised our estimates downwards for FY19/FY2 to Rs2.4/Rs4.2 (from Rs5.6/Rs7.3 earlier), respectively, and introduced our FY21 earnings estimate. We have assigned a higher discount while valuing ICEM with the replacement cost methodology to arrive at a fair value. We have retained Sell rating on the stock with a revised target price of Rs83 (from Rs12 earlier). Volume growth led by demand push in key markets: Volume rose ~14% YoY to 3.8mnmt on account of strong demand in Andhra Pradesh and Telangana, and also steady revival in Tamil Nadu. Capacity utilisation jumped to 77% from 67% YoY. However, realisation declined 2% YoY to Rs4,58/tn. Non-trade sales were higher at 45% of total sales. Realisation decline cushioned by limited cost inflation: Costs/tn were flat YoY at Rs4,4as a result of savings in other expenditure and logistics costs. Energy costs (adjusted to raw material costs) rose ~9% YoY on account of high pet-coke prices. Logistics costs fell 7.% YoY to Rs1,2/tn, which is commendable. Other expenditure increased ~16% YoY to Rs1.82bn. The fall in realisation was marginally offset by the compression in operating costs. However, despite this, EBITDA margin fell 31bps YoY to 11.2% and EBITDA/tn came in at Rs53 in, declining 24% from Rs663 in. Downward revision in our estimates: Considering the weak performance (higher slippage than estimated), we have revised downward our estimates. Although was the toughest quarter with limited passthrough and cost increase in some pockets, we feel ICEM s performance is unlikely to improve (better than industry) and stage a quick reversal. Cost pressure is likely to continue and price reversal in key ICEM markets will be slow. This, coupled with higher sales in non-trade segment, will result in working capital stress and lead to higher debt and increased interest costs. Factoring in the same, we have revised our estimates downwards for FY19/FY2 to Rs2.4/Rs4.2 (Rs5.6/Rs7.3 earlier), respectively, and introduced our FY21EPS estimate of Rs5.5. We expect EBITDA margin to hover ~12% (from 14% earlier) for the next two years as we expect cement prices to recover only marginally from the current lull. Outlook: We have valued ICEM stock at Rs4.bn/mt, at a deep discount of 45% to replacement costs of Rs7.5bn/mt to arrive at a fair value, and retained our Sell rating on it with a revised target price of Rs83 (from Rs12 earlier). We will revisit the deep discount assigned to ICEM in case of a sustained recovery in its performance and assign a lower discount. However, we have currently assigned a higher discount based on the current weak performance. At our target price, the stock trades at EV/EBITDA of ~8.x September 22E earnings. SELL Sector: Cement CMP: Rs91 Target Price: Rs83 Downside: 9% Milind Raginwar Research Analyst milind.raginwar@nirmalbang.com +91-22-6273 8172 Key Data Current Shares O/S (mn) 39.7 Mkt Cap (Rsbn/US$mn) 28.2/386.6 52 Wk H / L (Rs) 26/8 Daily Vol. (3M NSE Avg.) 6,399,855 Price Performance (%) 1 M 6 M 1 Yr The India Cements (5.) (33.7) (46.7) Nifty Index.1 (3.) 1.6 Source: Bloomberg Y/E March (Rsmn) YoY % QoQ % Net sales 13,871 12,683 9.4 13,67 1.9 Operating expenses 12,322.8 1,868.4 13.4 12,45.6 2.3 EBITDA 1,548 1,814 (14.7) 1,561 (.8) EBITDA margin (%) 11.2 14.3 (315bps) 11.5 (31bps) Other income 38 66-55 (31.3) Interest costs 836 886 (5.7) 733 14.1 Depreciation 617 632 (2.4) 616.2 PBT 132 362 (63.4) 267 (5.4) Non-recurring items (118) - - - - PBT (after non-recurring items) 14 362 (96.) 267 (94.6) Tax 51 77 (34.2) 138 (63.1) Reported PAT 14 237 (94.) 21 (93.2) Adjusted PAT 132 237 (44.1) 21 (37.) NPM (%) 1. 1.9 (91bps) 1.5 (59bps) Adjusted EPS (Rs).43.8 (44.3).7 (37.1) Source: Company, Nirmal Bang Research

Key conference-call takeaways ICEM s management indicated 14% volume growth of the overall cement industry, while ICEM grew in line with industry growth. Capacity utilisation in 1HFY19 stood at 77% vs. 67% in 1HFY18 and 73% in. ICEM is expecting it to improve further in 2HFY19. ICEM has entered into a share purchase agreement with Springway Mining Private Limited in a phased manner for ~Rs1.8bn. The management expects environmental clearance within a year and commercial operations from January 221. Cement capacity will increase by 2.2mt. ICEM has completed capex of Rs25mn and expects capex of ~Rs1.bn over the next two years. ICEM has total debt of Rs33bn, out of which Rs26bn is term debt. ICEM expects to repay Rs1.5bn of term debt by the end of this year. Currently, the trade/non-trade mix for ICEM is 55% and 45%, respectively. There is heavy demand from the non-trade segment because of infrastructure, irrigation and affordable housing projects. There is an impact on the working capital cycle as there is a delay in payment from the non-trade segment. 2 The India Cements

Exhibit 1: Operational details (Rs) YoY % QoQ % E Deviation % Volume (mnmt) 3.8 2.7 13.9 3.8.1 3.3 1.7 Cement realisation (net of freight) (Rs/mt) 4,58 4,583 (1.6) 4,323 4.3 4,413 2.1 Operating costs (Rs/mt) 4,4 4,9 (.1) 3,917 2.2 4,23 (.5) EBITDA (Rs/mt) 53 663 (24.1) 499.8 5.6 Source: Company, Nirmal Bang Research Exhibit 2: Detailed quarterly financials (Rsmn) YoY % QoQ % E Deviation % Net sales 13,871 12,683 9.4 13,67 1.9 13,686 1.3 Expenditure Change in stock (14.7) 71. (298.2) (21.4) (33.1) (11.) 27.9 Raw material costs 2,556.3 2,181.8 17.2 2,543.9.5 2,541.1.6 Purchased products 1 39 (97.4) 1. (5) (12.) Power & fuel expenses 4,73 2,974 37. 4,4 1.7 4,2 1.8 Freight costs 3,139 2,966 5.9 3,217 (2.4) 3,222 (2.6) Employee costs 872 1,64 (18.) 938 (7.) 999 (12.7) Other exp 1,821 1,574 15.7 1,552 17.3 1,515 2.2 Total operating expenses 12,322 1,829 13.8 12,45 2.3 12,169 1.3 EBITDA 1,548 1,814 (14.7) 1,561 (.8) 1,512 2.4 EBITDA margin (%) 11.2 14.3 (315bps) 11.5 (31bps) 11. 11bps Other income 38 66-55 (31.3) 38 (.3) Interest costs 836 886 (5.7) 733 14.1 722 15.8 Depreciation 617 632 (2.4) 616.2 622 (.8) PBT 132 362 (63.4) 267 (5.4) 26 (35.7) Non-recurring items (118) - - - - - - PBT (after non-recurring items) 132 362 (63.4) 267 (5.4) 26 (35.7) Tax - 125 (1.) 57 (1.) 58 (1.) Tax rate (%) - 35 (1bps) 21 (1bps) 28 (1bps) Reported PAT 14 237 (94.) 21 (93.2) 148 (9.4) Adjusted PAT 132 237 (44.1) 21 (37.) 148 (1.7) NPM (%) 1. 1.9 (91bps) 1.5 (59bps) 1.1 (13bps) Adjusted EPS (Rs).43.8 (44.3).7 (37.1).5 (11.1) Source: Company, Nirmal Bang Research Exhibit 3: Trend in operating costs/mt Operating costs/mt(rs) YoY % QoQ % Consumption of raw material 877 362 738 836 834 853 89 759 785 (5.9) 3.5 Power and fuel costs 864 1,7 1,113 1,76 1,11 1,124 1,131 1,32 1,324 2.2 1.7 Freight costs 1,45 1,31 1,72 1,72 1,98 1,31 1,74 1,46 1,2 (7.1) (2.5) Total costs per mt 3,844 4,461 3,978 4,14 4,9 3,814 4,24 3,917 4,4 (.1) 2.2 Source: Company, Nirmal Bang Research 3 The India Cements

Exhibit 4: Change in our estimates Old estimates New estimates Change (%) (Rsmn) FY19E FY2E FY19E FY2E FY19E FY2E Net sales 58,125 64,778 57,791 65,357 (.6).9 Operating profit 8,113 9,172 6,788 8,93 (16.3) (11.8) Net profit 1,724 2,262 739 1,292 (57.1) (42.9) EPS (Rs) 5.59 7.34 2.4 4.2 (57.1) (42.9) Target price (Rs) 12 83 Rating Sell Sell Source: Company, Nirmal Bang Research 4 The India Cements

Exhibit 5: Double-digit volume gain continues (Rsmn) (%) 2.9 3.9 3.75 3.77 6 3.3 2.48 2.66 2.7 2.73 5 2.8 2.17 2.31 2.4 2.36 2.3 1.94 4 1.8 3 1.3 2.8 1.3 (.2) (.7) (1) (1.2) (2) Exhibit 6: Realisation weakness continues (Rsmn) (%) 5, 15 4,75 1 4,5 5 4,25 (5) 4, (1) 3,75 (15) 3,5 (2) Volumes (mn mt) Growth (% YoY, RHS) Realisations (Rs/mt) Growth (% YoY, RHS) Source: Company, Nirmal Bang Research Exhibit 7: EBITDA/mt impacted by lower realisation Source: Company, Nirmal Bang Research Exhibit 8:Cost control via lower logistics and other expenses (Rsmn) 1,1 1, 9 8 7 6 5 4 3 1,5 791 837 89 964 887 668 731 663 69 52 499 53 (Rsmn) (%) 5, 15 4,5 4, 1 3,5 5 3, 2,5 2, (5) 1,5 (1) 1, 5 (15) - (2) EBITDA/mt Operating costs/mt (Rs) Growth (% YoY, RHS) Source: Company, Nirmal Bang Research Exhibit 9: Freight cost control helps lower overall costs (Rsmn) (%) 1,15 15 1,1 1 1,5 5 1, 95 (5) 9 (1) 85 (15) Source: Company, Nirmal Bang Research Exhibit 1: Energy cost inflation offsets the benefits (Rsmn) (%) 1,4 4 1,2 3 1, 2 8 1 6 4 (1) 2 (2) - (3) Freight costs/mt (Rs) Growth (% YoY, RHS) Power & Fuel costs/mt (Rs) Growth (% YoY, RHS) Source: Company, Nirmal Bang Research Source: Company, Nirmal Bang Research 5 The India Cements

Apr-9 Jul-9 Nov-9 Mar-1 Jul-1 Nov-1 Mar-11 Jul-11 Nov-11 Mar-12 Jul-12 Nov-12 Mar-13 Jul-13 Nov-13 Mar-14 Jul-14 Nov-14 Mar-15 Jul-15 Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 Nov-18 Apr-9 Jul-9 Nov-9 Mar-1 Jul-1 Nov-1 Mar-11 Jul-11 Nov-11 Mar-12 Jul-12 Nov-12 Mar-13 Jul-13 Nov-13 Mar-14 Jul-14 Nov-14 Mar-15 Jul-15 Nov-15 Mar-16 Jul-16 Nov-16 Mar-17 Jul-17 Nov-17 Mar-18 Jul-18 Nov-18 Exhibit 11: Valuation charts EV/EBITDA (Rs) 4 35 3 25 2 15 1 5 EV/tn (Rs) 35 3 25 2 15 1 5 Price 7 1 12 14 Source: Company, Nirmal Bang Research Price $45 $6 $75 $9 $15 Source: Company, Nirmal Bang Research 6 The India Cements

Financials Exhibit 12: Income statement Y/E March (Rsmn) FY17 FY18 FY19E FY2E FY21E Net sales 5,792 51,755 57,791 65,357 73,222 Growth (%) 2.2 1.9 11.7 13.1 12. Operating expenses (42,157) (44,738) (51,3) (57,264) (64,313) EBITDA 8,635 7,18 6,788 8,93 8,99 Growth (%) 11.2 (18.7) (3.3) 19.2 1.1 Depreciation &amortisation (2,571) (2,559) (2,497) (2,84) (2,887) EBIT 6,25 4,563 4,395 5,384 6,132 Other income 141 15 14 96 11 Interest paid (3,65) (3,42) (3,382) (3,63) (3,796) Extraordinary/exceptional items PBT 2,61 1,161 1,13 1,782 2,337 Tax (867) (155) (273) (49) (643) Effective tax rate (%) (33) (13) (27) (28) (27) Net profit 1,734 1,6 739 1,292 1,694 Minority interest Reported net profit 1,734 1,6 739 1,292 1,694 Non-recurring items Adjusted net profit 1,734 1,6 739 1,292 1,694 Growth (%) 23. (42.) (26.5) 74.7 31.1 Source: Company, Nirmal Bang Research Exhibit 14: Balance sheet Y/E March (Rsmn) FY17 FY18 FY19E FY2E FY21E Cash & bank balance 68 84 441 281 685 Other current assets 27,8 3,277 34,57 38,42 42,17 Investments 6,19 5,884 6,84 6,284 6,584 Net fixed assets 7,474 68,97 69,345 7,279 68,787 Goodwill & intangible assets 533 75 75 75 75 Other non-current assets 1,388 1,339 31 35 39 Total assets 16,453 17,258 111,392 116,31 119,321 Current liabilities 21,71 18,78 2,953 22,519 23,953 Borrowings 27,15 3,12 33,67 36,851 38,883 Other non-current liabilities 6,556 6,532 5,194 4,884 4,534 Total liabilities 55,362 55,253 59,816 64,254 67,37 Share capital 3,72 3,82 3,82 3,82 3,82 Reserves & surplus 48,17 48,922 48,494 48,966 48,869 Shareholders' funds 51,91 52,5 51,576 52,47 51,951 Minority interest Total equity & liabilities 16,453 17,258 111,392 116,31 119,321 Source: Company, Nirmal Bang Research Exhibit 13: Cash flow Y/E March (Rsmn) FY17 FY18 FY19E FY2E FY21E Pre-tax profit 2,61 1,161 1,13 1,782 2,337 Depreciation 2,617 (29,395) 2,545 2,497 2,84 Chg. in working capital (256) 6,288 (5,68) (2,375) (2,485) Total tax paid (293) 1,914 (531) (441) (683) Other operating activities Operating CF 4,71 (18,592) (1,893) 694 1,418 Capital expenditure (892) (6,589) (1,212) (2,872) (3,739) Chg in investments (3) 9,664 37 (2) (2) Other investing activities Investing CF (894) 3,76 (96) (3,72) (3,939) FCF (15,517) (2,799) (2,378) (2,521) 162 Equity raised/(repaid) 62 1 (2) () () Debt raised/(repaid) 3,53 2,98 3,657 3,181 2,32 Dividend (incl. tax) (741) (371) (247) (247) Other financing activities 13,174 268 (92) (574) (1,544) Financing CF 15,547 2,815 2,735 2,361 242 Net chg in cash & bank bal. 3 16 357 (16) 44 Closing cash & bank bal 68 84 441 281 685 Source: Company, Nirmal Bang Research Exhibit 15: Key ratios Y/E March (Rsmn) FY17 FY18 FY19E FY2E FY21E Profitability and return ratios (%) EBITDAM 17. 13.6 11.7 12.4 12.2 EBITM 12.2 8.8 7.6 8.2 8.4 NPM 3.4 1.9 1.3 2. 2.3 RoE 4. 2. 1.4 2.5 3.3 RoCE 8.3 5.3 4.9 5.8 6.5 RoIC 8.1 6.7 5.1 5.9 6.5 Per share data (Rs) O/s shares 37.2 37.2 37.2 37.2 37.2 EPS 5.6 3.3 2.4 4.2 5.5 FDEPS 5.6 3.3 2.4 4.2 5.5 CEPS 14. 11.6 1.5 13.3 14.9 BV 1.7 13.3 13.7 17. 18.5 DPS 1.2 1.2.8.8.8 Valuation ratios (x) P/E 16.3 28.2 38.3 21.9 16.7 P/BV.9.9.9.9.8 EV/EBITDA 6.4 8.3 9.1 8. 7.5 EV/Sales 1.1 1.1 1.1 1..9 Other key ratios D/E (x).5.6.6.7.7 DSO (days) 37 44 47 48 49 DuPont analysis - RoE NPM (%) 3.4 1.9 1.3 2. 2.3 Asset turnover (x).5.5.5.6.6 Equity multiplier (x) 2.2 2.1 2.1 2.2 2.3 RoE (%) 4. 2. 1.4 2.5 3.3 Source: Company, Nirmal Bang Research 7 The India Cements

Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 Jan-18 Feb-18 Mar-18 Apr-18 May-18 Jun-18 Jul-18 Aug-18 Sep-18 Oct-18 Nov-18 Rating track Date Rating Market price (Rs) Target price (Rs) 26 March 218 Sell 141 126 28 May 218 Sell 13 119 6 June 218 Sell 113 17 14 August 218 Sell 18 12 12 November 218 Sell 91 83 Rating track graph 25 23 21 19 17 15 13 11 9 7 Not Covered Covered 8 The India Cements

DISCLOSURES This Report is published by Nirmal Bang Equities Private Limited (hereinafter referred to as NBEPL ) for private circulation. NBEPL is a registered Research Analyst under SEBI (Research Analyst) Regulations, 214 having Registration no. INH1436. NBEPL is also a registered Stock Broker with National Stock Exchange of India Limited and BSE Limited in cash and derivatives segments. NBEPL has other business divisions with independent research teams separated by Chinese walls, and therefore may, at times, have different or contrary views on stocks and markets. NBEPL or its associates have not been debarred / suspended by SEBI or any other regulatory authority for accessing / dealing in securities Market. NBEPL, its associates or analyst or his relatives do not hold any financial interest in the subject company. NBEPL or its associates or Analyst do not have any conflict or material conflict of interest at the time of publication of the research report with the subject company. NBEPL or its associates or Analyst or his relatives do not hold beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of this research report. NBEPL or its associates / analyst has not received any compensation / managed or co-managed public offering of securities of the company covered by Analyst during the past twelve months. NBEPL or its associates have not received any compensation or other benefits from the company covered by Analyst or third party in connection with the research report. Analyst has not served as an officer, director or employee of Subject Company and NBEPL / analyst has not been engaged in market making activity of the subject company. Analyst Certification: Mr. Milind Raginwar, the Research Analyst is the author of this report, hereby certify that the views expressed in this research report accurately reflects my/our personal views about the subject securities, issuers, products, sectors or industries. It is also certified that no part of the compensation of the analyst(s) was, is, or will be directly or indirectly related to the inclusion of specific recommendations or views in this research. The analyst(s) principally responsible for the preparation of this research report and has taken reasonable care to achieve and maintain independence and objectivity in making any recommendations. 9 The India Cements

Disclaimer Stock Ratings Absolute Returns BUY > 15% ACCUMULATE -5% to15% SELL < -5% This report is for the personal information of the authorized recipient and does not construe to be any investment, legal or taxation advice to you. NBEPL is not soliciting any action based upon it. Nothing in this research shall be construed as a solicitation to buy or sell any security or product, or to engage in or refrain from engaging in any such transaction. In preparing this research, we did not take into account the investment objectives, financial situation and particular needs of the reader. This research has been prepared for the general use of the clients of NBEPL and must not be copied, either in whole or in part, or distributed or redistributed to any other person in any form. If you are not the intended recipient you must not use or disclose the information in this research in any way. Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. NBEPL will not treat recipients as customers by virtue of their receiving this report. This report is not directed or intended for distribution to or use by any person or entity resident in a state, country or any jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject NBEPL & its group companies to registration or licensing requirements within such jurisdictions. The report is based on the information obtained from sources believed to be reliable, but we do not make any representation or warranty that it is accurate, complete or up-to-date and it should not be relied upon as such. We accept no obligation to correct or update the information or opinions in it. NBEPL or any of its affiliates or employees shall not be in any way responsible for any loss or damage that may arise to any person from any inadvertent error in the information contained in this report. NBEPL or any of its affiliates or employees do not provide, at any time, any express or implied warranty of any kind, regarding any matter pertaining to this report, including without limitation the implied warranties of merchantability, fitness for a particular purpose, and noninfringement. The recipients of this report should rely on their own investigations. This information is subject to change without any prior notice. NBEPL reserves its absolute discretion and right to make or refrain from making modifications and alterations to this statement from time to time. Nevertheless, NBEPL is committed to providing independent and transparent recommendations to its clients, and would be happy to provide information in response to specific client queries. Before making an investment decision on the basis of this research, the reader needs to consider, with or without the assistance of an adviser, whether the advice is appropriate in light of their particular investment needs, objectives and financial circumstances. There are risks involved in securities trading. The price of securities can and does fluctuate, and an individual security may even become valueless. International investors are reminded of the additional risks inherent in international investments, such as currency fluctuations and international stock market or economic conditions, which may adversely affect the value of the investment. Opinions expressed are subject to change without any notice. Neither the company nor the director or the employees of NBEPL accept any liability whatsoever for any direct, indirect, consequential or other loss arising from any use of this research and/or further communication in relation to this research. Here it may be noted that neither NBEPL, nor its directors, employees, agents or representatives shall be liable for any damages whether direct or indirect, incidental, special or consequential including lost revenue or lost profit that may arise from or in connection with the use of the information contained in this report. Copyright of this document vests exclusively with NBEPL. Our reports are also available on our website www.nirmalbang.com Access all our reports on Bloomberg, Thomson Reuters and Factset. Team Details: Name Email Id Direct Line Rahul Arora CEO rahul.arora@nirmalbang.com - Girish Pai Head of Research girish.pai@nirmalbang.com +91 22 6273 817 / 18 Dealing Ravi Jagtiani Dealing Desk ravi.jagtiani@nirmalbang.com +91 22 6273 823, +91 22 6636 8833 Pradeep Kasat Dealing Desk pradeep.kasat@nirmalbang.com +91 22 6273 81/811, +91 22 6636 8831 Michael Pillai Dealing Desk michael.pillai@nirmalbang.com +91 22 6273 812/813, +91 22 6636 883 Nirmal Bang Equities Pvt. Ltd. Correspondence Address B-2, 31/32, Marathon Innova, Nr. Peninsula Corporate Park, Lower Parel (W), Mumbai-413. Board No. : 91 22 6273 8/1; Fax. : 22 6273 81 1 The India Cements